Matthew Blakiston
-
- Antibiotic Use and Resistance 3
-
- Tuberculosis Research and Epidemiology 3
- COVID-19 Clinical Research Studies 3
-
- Antibiotic Resistance in Bacteria 3
-
- Respiratory viral infections research 3
- Pneumonia and Respiratory Infections 2
-
- Bacterial Identification and Susceptibility Testing 3
-
- Vibrio bacteria research studies 2
- Co-authors
- Susan C. MorpethJoshua T. FreemanSusan TaylorConroy WongSally RobertsLovett LawsonLuís E. CuevasOlanrewaju Oladimeji
- Cited by
- Applied Microbiology and BiotechnologyInfectious DiseasesCritical Care and Intensive Care Medicine
- Partner nations
- New ZealandUnited KingdomNigeria
In The Last Decade
Matthew Blakiston
15 papers receiving 141 citations
Peers
Comparison fields: 5 of 48
- Applied Microbiology and Biotechnology 10
- Infectious Diseases 68
- Critical Care and Intensive Care Medicine 13
- Molecular Medicine 9
- Organizational Behavior and Human Resource Management 15
Countries citing papers authored by Matthew Blakiston
This map shows the geographic impact of Matthew Blakiston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Blakiston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Blakiston more than expected).
Fields of papers citing papers by Matthew Blakiston
This network shows the impact of papers produced by Matthew Blakiston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Blakiston. The network helps show where Matthew Blakiston may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew Blakiston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 14 | |
| 8 | Age-related differences in SARS-CoV-2 testing in the Northern Region of New Zealand. | 2020 | 1 |
| 9 | Population-level exposures associated with MRSA and ESBL-E. coli infection across district health boards in Aotearoa New Zealand: an ecological study. | 2020 | 4 |
| 10 | 2019 | 1 | |
| 11 | 2019 | 5 | |
| 12 | 2018 | 7 | |
| 13 | 2018 | 24 | |
| 14 | 2016 | 6 | |
| 15 | 2015 | 13 | |
| 16 | 2015 | 28 | |
| 17 | 2008 | 31 | |
| 18 | Cigarettes and Candy A Study of Retailer Compliance with the Point of Sale Tobacco Display Regulations in the 2003 Smoke-free Environments Amendment Act | 2006 | 3 |
About Matthew Blakiston
Matthew Blakiston is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 18 papers that have together received 148 indexed citations. Recurring topics across this work include Respiratory viral infections research (3 papers), Tuberculosis Research and Epidemiology (3 papers), Antibiotic Use and Resistance (3 papers), Antibiotic Resistance in Bacteria (3 papers), COVID-19 Clinical Research Studies (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Vibrio bacteria research studies (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (10 citations), Infectious Diseases (68 citations) and Critical Care and Intensive Care Medicine (13 citations). Matthew Blakiston has collaborated with scholars based in New Zealand, United Kingdom and Nigeria. Frequent co-authors include Susan C. Morpeth, Joshua T. Freeman, Susan Taylor, Conroy Wong, Sally Roberts, Lovett Lawson, Luís E. Cuevas, Olanrewaju Oladimeji, Nikhil Sapre and Joshua Obasanya.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.